Hidalgo launches new range of Equivital vital signs monitor
29 November 2011
Cambridge, UK. Wireless innovations company Hidalgo has
launched its latest range of mobile vital signs monitors, the Equivital
The technology could revolutionise the future of the healthcare
and pharmaceutical industries worldwide, with customers already
including NHS hospitals and international research bodies.
“The Equivital personal devices are designed to be used on a
‘wear and forget’ principle and the latest product range is being
appreciated for this quality,” says Dr Ekta Sood from Hidalgo.
The new Equivital EQ02 LifeMonitor incorporates a miniaturised
body-worn sensor module that senses, records, processes and
transmits data from the human body.
Equivital EQ02 LifeMonitors in docking station
The data includes physiological parameters such as ECG,
respiration rate and body temperature but importantly can be used to
derive information — for example for biometric verification — or for
creating indexes such as for stress monitoring. Using external
sensors the LifeMonitor data channels can include oxygen saturation,
galvanic skin response, and core body temperature.
In combination with the qView PC, mobile and web based software
platform, the LifeMonitor sends information to be viewed and, where
applicable, further analysed or acted upon.
“Having the ability to measure and model physiological
information about the human body — in both health and disease states
and on a mass scale — will lead to a better understanding of its
cause and effect behaviours and catalyse an era of more proactive
and personalised healthcare,” explained Dr Sood.
“Hidalgo is developing devices and software which can do this in
real time so that in the future, for example, timely and appropriate
action can be taken if patterns of data from the person under
“What the Equivital brand stands for will ultimately enable an
important shift in the level of control an individual can have on
their own personal health and wellbeing by being better informed.”
The devices are already being put to good use in the healthcare and
pharmaceutical fields. A trial funded by Oxford Biomedical Research
Centre and the Wellcome Trust — and run by a team at Churchill
Hospital and Oxford University — is using the Equivital LifeMonitor
to continuously monitor haemodialysis patients. Such patients are at
a much higher risk of sudden and potentially fatal emergencies.
Using human data taken before, during and after haemodialysis,
the team is developing an index that pro-actively alerts clinicians
to the likelihood of a life threatening event. This could enable
timely intervention and prevent adverse situations.
Orders have already been received for the new EQ02 Equivital
LifeMonitor system through distributors around the world.
Mobile human health monitoring technologies offer a significant
advance in both personalising healthcare and extending care from the
hospital into the community and the home. Hidalgo, which is at the
cutting edge of this emerging field, believes it will see a rapid
increase in the uptake and availability of such systems in the next